Bristol-myers Squibb Stock News

Riding the Oracle of Omaha's coattails has been a successful investing strategy for over five decades.

Riding the Oracle of Omaha's coattails has been a successful investing strategy for over five decades.

Bristol-Myers Squibb continues to deliver excellent results, making the stock one of the best deep value picks in the biopharma sector. Management expects solid growth rates through 2029 thanks to str

Bristol-Myers reported its Q4 and full-year financial results on Friday.

SDOG: High Yield, Good Value, Questionable Quality

BMY earnings call for the period ending December 31, 2021.

BMY earnings call for the period ending December 31, 2021.

Bristol-Myers (BMY) earnings match estimates in the fourth quarter of 2021, while sales beat the same on the back of Eliquis and Opdivo.

Shares of Bristol-Myers Squibb Co (NYSE: BMY) jumped 3.0% on Friday morning after the pharmaceutical giant reported its Q4 results and offered guidance for fiscal 2022. Q4 financial performance Bristo

Bristol Myers Squibb topped fourth-quarter estimates on Friday and issued in-line earnings guidance. BMY stock rose in response.

Bristol-Myers Squibb Co (BMY) CEO Giovanni Caforio on Q4 2021 Results - Earnings Call Transcript

Bristol-Myers (BMY) earnings match estimates in the fourth quarter of 2021, while sales beat the same on the back of Eliquis and Opdivo.

Futures Reverse Overnight Gains As Amazon Euphoria Fizzles We warned last night that the surge in futures following the huge bounce in Amazon stock wouldn''t last (simply because a closer read of the company''s earnings left a lot to be desired) and sure enough, in the overnight (extremely illiquid) session, 500 futures erased gains of as much as 1.3% to trade 0.1% lower, or 10 points, to 4,460 as European stocks extend their decline as inflation and monetary tightening outweighed earnings optimism. Meanwhile, Nasdaq 100 futures pared much of their gains, trading just 0.5% higher after earlier rising more than 2%, one day after the index had the worst day since September 2020. The VIX increased for a third day Friday, hovering just below 26. The dollar dropped as the EUR surge continued, following yesterday''s unexpectedly hawkish comments from Lagarde ... while oil was on course for a seventh weekly advance with Brent rising Relief, as brief as it was, was welcome after a 4.2% crash in the Nasdaq 100 Index on Thursday, its biggest since 2020, fueled by a 26% rout in Meta Platforms following disappointing results.

Bristol Myers Squibb posted stronger-than-expected fourth quarter earnings Thursday, while repeating its financial guidance for the coming year, thanks to impressive sales gains for its cancer and blood clot treatments.